BridgeMD
Continuing Anticoagulants and Antiplatelets in Cold snare Polypectomy.
EU CTIS ID: 2024-511265-11-01
What this study is testing
To demonstrate that the risk of postpolypectomy hemorrhage (immediate relevant or delayed) of non-pedunculated polyps smaller than 10mm removed with a cold snare, in patients under antiplatelet or anticoagulant treatment, is not higher than that of the control group from which said treatment will have been withdrawn according to the guidelines of current clinical practice
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Subjects between 18 and 80 years old for whom a colonoscopy has been requested for any indication
- Subjects who are under chronic antiplatelet therapy (other than ASA) or anticoagulant treatment.
You likely can't join if
- Coronary stent implantation in the previous 6 months or double antiplatelet therapy.
- Severe comorbility (ASA >3)
- Decompensated liver cirrhosis
- Express refusal to participate in the study.
- Cardiovascular or thromboembolic event (ischemic heart disease, cerebrovascular event, venous thromboembolic disease) in the previous 6 months.
- Combined treatment with anticoagulants and antiplatelets
See the full eligibility criteria
- Subjects between 18 and 80 years old for whom a colonoscopy has been requested for any indication
- Subjects who are under chronic antiplatelet therapy (other than ASA) or anticoagulant treatment.
- Coronary stent implantation in the previous 6 months or double antiplatelet therapy.
- Severe comorbility (ASA >3)
- Decompensated liver cirrhosis
- Express refusal to participate in the study.
- Cardiovascular or thromboembolic event (ischemic heart disease, cerebrovascular event, venous thromboembolic disease) in the previous 6 months.
- Combined treatment with anticoagulants and antiplatelets
- Chronic kidney disease grade 4 or higher, defined as a Creatinine clearance less than 30 ml/min.
- Pregnancy or breastfeeding
- Hemodialysis
- Thrombophilia or known clotting disorders. Thrombopenia < 50000 platelets/mm3.
- Urgent colonoscopy
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.